Functional characterization of miRNA(s) that regulate(s) apoptosis by Adlakha, Yogita K
Functional characterization of miRNA(s) that regulate(s) apoptosis

Apoptosis is an efficient and highly regulated type of programmed cell death by which unwanted and deleterious cells are removed from the body. It is highly active and tightly controlled phenomenon that plays a fundamental role in the maintenance of tissue homeostasis and development. Dysfunction of the apoptotic program is often implicated in variety of diseases. Evasion of apoptosis underlies tumorigenesis whereas progressive cell loss due to apoptosis is a pathological hallmark of various degenerative diseases including heart disease, atherosclerosis and neurodegenerative disorders.

microRNAs are small, 20-25 nt long, genome encoded non-coding RNA molecules which regulate gene expression post-transcriptionally. They were initially discarded as cellular detritus, but a decade ago, they have gained a overwhelming attention due to their huge number and each one of them targeting a vast number of functionally related genes. Reports in literature suggest that same microRNA can target multiple genes and thus influence many physiological processes together. Their profound impact on several patho-physiological processes including development, differentiation, proliferation, apoptosis and metabolism make them focus of interest for therapeutic intervention.

In the present thesis, we show that the over expression of hsa-miR-128 in human embryonic kidney (HEK293T) cells induces mitochondrial-mediated apoptosis as proved by the annexin assay, cell cycle changes, caspase activation, mitochondrial membrane disruption, release of cytochrome-c from mitochondria to cytoplasm. Furthermore, the hsa-miR-128 modulated the expression of a number of genes involved in apoptosis including Bax (Bcl-2 Associated X protein). Bioinformatically, Bax is predicted to be the target of hsa-miR-128. In the current study, we validated Bax as the target of hsa-miR-128. It negatively regulated the expression of Bax 3’UTR construct as shown by luciferase assay. Besides this, hsa-miR-128 also upregulated the expression of p53 and Bak.

To delineate the molecular mechanism(s) responsible for hsa-miR-128 induced apoptosis, gene expression profiling was carried out after hsa-miR-128 over expression in HEK293T cells. The microarray analysis yielded 182 differentially expressed genes and analysis of the gene expression data with Ingenuity Pathway Analysis (IPA) software revealed cell death among the top three molecular and cellular functions, which strengthened our previous study. The top three associated networks shown by IPA included cancer, cellular growth and proliferation, gene expression; hematological system development and function, hematological disease; cell cycle, cancer, DNA replication, recombination and repair. We further showed that hsa-miR-128 inhibited SIRT1 expression directly through a miR-128-binding site within the 3’UTR of SIRT1. miR-128 not only upregulated acetylated p53, its transcriptional activity and its targets (PUMA, Noxa) but also increased acetylation of FOXO3A and promoted FOXO3A translocation to the nucleus. Our study further demonstrated that miR-128 augmented the anti-tumor effect of the drugs that target the p53 pathway. We also observed that hsa-miR-128 induced apoptosis in wild type (WT) p53 (MCF-7) as well as in mutant p53-expressing (MDA-MB-231) cells in a p53- dependent and- independent manner via induction of PUMA. Pretreatment with PUMA and Bak siRNAs abolished miR-128 induced apoptosis in HCT116 p53+/+ and HCT116 p53-/- cells.

We here present the first evidence of hsa-miR-128 to be a new component joining the p53 network. This study emphasizes that miR-128 is a novel mitochondria targeted miRNA which can be further evaluated as a chemotherapeutic agent for human cancers since it induces apoptosis irrespective of p53 status. Introduction of hsa-miR-128 into in-vivo disease models would help evaluate the prospect of its use as a therapeutic in diseases known to occur because of deregulation of apoptosis. Further analysis also showed that PPAR?, LXR (liver X receptor) /RXR (retinoid  receptor) mediated cholesterol and fatty acid biosynthesis pathways are the most significantly enriched pathway. Our findings provided important evidence for the potential role of hsa-miR-128 in metabolism besides apoptosis, which needs further investigation.


